Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Maquet Critical Care AB is navigating 2 pending office actions within the Medical Devices & Mechanical Engineering technology area. These actions are distributed across 2 distinct examiners, which requires the company to manage different examination styles simultaneously. Despite the involvement of multiple examiners, all current activity is localized within 1 distinct art unit. This suggests that while the technical scope of the filings is specialized, the company must address the perspectives of different officials within that single administrative unit. The concentration in 1 distinct art unit provides a stable administrative environment for these filings.
BORISSOV, IGOR N is identified as the busiest examiner for this portfolio, currently handling 1 pending office action. Since the 2 pending office actions are split between the 2 distinct examiners, the workload is shared between the officials. This distribution within 1 distinct art unit means that practitioners must be prepared for varied interpretations of similar technical subject matter. The company's strategy in the Medical Devices & Mechanical Engineering field must remain flexible enough to accommodate these different examiner approaches, even when dealing with only 2 pending office actions.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BORISSOV, IGOR N | 1 | 28.5% | +41.8% |
| ZHANG, TINA | 1 | 56.7% | +43.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16900817 | BREATHING SYSTEM COMPONENT AND A PROCESS FOR THE MANUFACTURE OF THE BREATHING SYSTEM COMPONENT | ZHANG, TINA | 14d |
| 18872160 | CONTROL OF CARBON DIOXIDE TRANSFER IN OXYGENATOR FOR EXTRACORPOREAL BLOOD GAS EXCHANGE | BORISSOV, IGOR N | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16900817 | BREATHING SYSTEM COMPONENT AND A PROCESS FOR THE MANUFACTURE OF THE BREATHING SYSTEM COMPONENT | ZHANG, TINA | 14d |
| 18872160 | CONTROL OF CARBON DIOXIDE TRANSFER IN OXYGENATOR FOR EXTRACORPOREAL BLOOD GAS EXCHANGE | BORISSOV, IGOR N | — |
| Art Unit | Apps |
|---|---|
| 3785 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18872160 | CONTROL OF CARBON DIOXIDE TRANSFER IN OXYGENATOR FOR EXTRACORPOREAL BLOOD GAS EXCHANGE | BORISSOV, IGOR N | — | §101§102 | Non-Final OA | — | Pending | Dec 05, 2024 |
| 16900817 | BREATHING SYSTEM COMPONENT AND A PROCESS FOR THE MANUFACTURE OF THE BREATHING SYSTEM COMPONENT | ZHANG, TINA | 3785 | §103§112 | Final Rejection | 14d | Pending | Jun 12, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial